Presented by Dr James Rush
Autoimmunity,
Transplantation and Inflammation Diseases, Novartis Institutes for BioMedical Research (NIBR)
Basel, Switzerland
Dr. James Rush is a Senior Investigator in the Autoimmunity,
Transplantation and Inflammation disease area at the Novartis Institutes for
BioMedical Research (NIBR) in Basel. His lab focuses on translational
immunology research and the development of therapeutics targeting
co-stimulation pathways dysregulated in autoimmunity. Areas of interest include
utilizing ‘omics technologies to classify autoimmune diseases at the molecular
level, translational research and human immunology. After completing a PhD in
cellular immunology at the Centenary Institute with Dr. Phil Hodgkin, he was a
HHMI postdoctoral researcher at Yale University in the laboratories of David
Schatz and Charlie Janeway. Subsequently he joined the Genomics Institute of
the Novartis Research Foundation in San Diego in May 2005 where his lab
utilized high throughput genomics and small molecule screening technologies to
identify novel regulators of innate immune receptor and B cell function. He
then moved to NIBR Basel in 2008 to lead the development of a novel
immunomodulatory drug for transplantation and antibody-mediated autoimmune
diseases that is now undergoing clinical evaluation.
Further information available from CID Weekly Seminar Series website [http://www.med.monash.edu.au/scs/medicine/cid/seminar-series.html]
No comments:
Post a Comment